New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?-Reference-Cited by-同舟云学术

New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?

Published:2024-11 Issue: Volume:209 Page:107456
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Campagnoli Lucrezia Irene Maria,Marchesi Nicoletta,Varesi Angelica,Morozzi Martina,Mascione Linda,Ricevuti Giovanni,Esposito Ciro,Galeotti Nicoletta,Pascale Alessia

Publisher

Elsevier BV

Reference251 articles.

1. Multiple sclerosis – a review;Dobson;Eur. J. Neurol.,2019

2. Why is multiple sclerosis more frequent in women? Role of the immune system and of oral and gut microbiota;D’Anca;Appl. Sci.,2023

3. Blood-brain barrier disruption in multiple sclerosis;Minagar;Mult. Scler.,2003

4. Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier;Spencer;J. Neurol. Neurosurg. Psychiatry,2018

5. Multiple sclerosis: an immune or neurodegenerative disorder?;Trapp;Annu Rev. Neurosci.,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immuno-nutritional therapy in experimental autoimmune encephalomyelitis: a translational pathway to multiple sclerosis management;Inflammopharmacology;2025-06-17

2. The gut-immune axis in primary immune thrombocytopenia (ITP): a paradigm shifts in treatment approaches;Frontiers in Immunology;2025-06-12

3. Breaking the Cycle: Can Vitamin D Bridge the Gap Between Gut Microbiota and Immune Dynamics in Multiple Sclerosis?;International Journal of Molecular Sciences;2025-06-07

4. Role of Gut Microbiota in Multiple Sclerosis (MS);Egyptian Journal of Chemistry;2025-05-01